The NICE reference case requirement: more pain for what, if any, gain?

Amiram Gafni, Stephen Birch

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)271-273
Number of pages3
JournalPharmacoEconomics
Volume22
Issue number4
DOIs
Publication statusPublished - Mar 2004

Keywords

  • Delivery of Health Care/economics
  • Drug Industry/economics
  • England
  • Quality-Adjusted Life Years
  • Technology Assessment, Biomedical/economics
  • Wales

Cite this